RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.67B
AUM Growth
-$1.54B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$82.4M
2
+$55.9M
3
+$47.2M
4
RLMD icon
Relmada Therapeutics
RLMD
+$45.1M
5
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
+$34.8M

Top Sells

1
+$190M
2
+$35.9M
3
+$21M
4
CTMX icon
CytomX Therapeutics
CTMX
+$17.8M
5
WHWK
Whitehawk Therapeutics
WHWK
+$10.2M

Sector Composition

1 Healthcare 98.88%
2 Financials 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
– –
-750,000
102
– –
-1,034
103
– –
-6,222
104
– –
-347,668
105
– –
-218,532
1 2 3 4
5